CTI BioPharma Corp. (DE) Common Stock (CTIC)

CTIC was delisted on the 23rd of June, 2023.

• Market cap: $1.2B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Employees: 128